Correction to: Polatuzumab Vedotin: First Global Approval

被引：0

作者：

Emma D. Deeks

机构：

[1] Springer Nature,

来源：

Drugs | 2019年 / 79卷 / 16期

关键词：

D O I：

10.1007/s40265-019-01214-w

中图分类号：

学科分类号：

摘要：

The article Polatuzumab Vedotin: First Global Approval, written by Emma D. Deeks, was originally published Online First without Open Access. After publication in volume 79, issue 13, pages 1467–1475 Roche/GCC requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Roche/GCC. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial.

引用

页码：1829 / 1829

共 50 条

[1] Polatuzumab Vedotin: First Global Approval
Deeks, Emma D.
[J]. DRUGS, 2019, 79 (13) : 1467 - 1475
[2] Polatuzumab Vedotin: First Global Approval
Emma D. Deeks
[J]. Drugs, 2019, 79 : 1467 - 1475
[3] Polatuzumab Vedotin: First Global Approval (vol 79, pg 1467, 2019)
Deeks, Emma D.
[J]. DRUGS, 2019, 79 (16) : 1829 - 1829
[4] Polatuzumab Vedotin
不详
[J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 16 - 17
[5] Correction to: Camrelizumab: First Global Approval
Anthony Markham
Susan J. Keam
[J]. Drugs, 2019, 79 (13) : 1497 - 1497
[6] Correction to: Caplacizumab: First Global Approval
Sean Duggan
[J]. Drugs, 2018, 78 (18) : 1955 - 1955
[7] Correction to: Mirogabalin: First Global Approval
Emma D. Deeks
[J]. Drugs, 2019, 79 (4) : 469 - 469
[8] Correction to: Ivosidenib: First Global Approval
Sohita Dhillon
[J]. Drugs, 2019, 79 (1) : 107 - 107
[9] Correction to: Revefenacin: First Global Approval
Young-A Heo
[J]. Drugs, 2019, 79 (6) : 689 - 689
[10] Correction to: Sarecycline: First Global Approval
Emma D. Deeks
[J]. Drugs, 2019, 79 (7) : 795 - 795

← 1 2 3 4 5 →